UK Risks Losing Global Life Sciences Edge as Pharma Investment Decline, ABPI Warns
The UK risks losing its world-leading position in life sciences as investment in pharmaceutical research and development continues to fall behind international competitors, according to a new report from the Association of the British Pharmaceutical Industry (ABPI).
Association Of The British Pharmaceutical Industry | 12/09/2025 | By Dineshwori
Pharma Leaders Back UK Life Sciences Strategy, But ABPI Warns of Medicines Investment Gap
Pharmaceutical and medical technology leaders, including GSK, Sandoz, Accord Healthcare, Becton Dickinson, and Celltrion have welcomed the UK government’s new Life Sciences Sector Plan, recently unveiled as part of its flagship Industrial Strategy.
Association Of The British Pharmaceutical Industry | 19/07/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy